• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种通过液相色谱-串联质谱法同时测定人血浆中阿米洛利和氢氯噻嗪的单一、选择性且简便的验证方法。

A single, selective and simple validated method for simultaneous estimation of amiloride and hydrochlorothiazide in human plasma by liquid chromatography-tandem mass spectrometry.

作者信息

Jangid Arvind G, Tale Rajesh H, Vaidya Vikas V

机构信息

School of Chemical Sciences, Swami Ramanand Teerth Marathwada University, Nanded, India.

出版信息

Biomed Chromatogr. 2012 Jan;26(1):95-100. doi: 10.1002/bmc.1632. Epub 2011 Apr 13.

DOI:10.1002/bmc.1632
PMID:21491473
Abstract

A single, simple and selective method for simultaneous estimation of amiloride and hydrochlorothiazide in human plasma was validated using triamterine and hydrochlorothiazide (13)C,d2 as internal standard. The compounds were separated on a reverse-phase column with an isocratic mobile phase consisting of 2 mm ammonium acetate pH 3.0 and acetonitrile (30:70, v/v) and detected by tandem mass spectrometry with positive/negative ion mode. The analytes and internal standards were extracted from plasma using simple solid phase extraction. The ion transitions recorded in multiple reaction monitoring mode were m/z 230.1 → 116.0 for amiloride, m/z 254.1 → 237.1 for internal standard, triamterine in positive mode and m/z 296.1 → 204.9 for hydrochlorothiazide, m/z 299.2 → 205.8 for internal standard, hydrochlorothiazide (13)C,d2 in negative ion mode. Linearity in plasma was observed over the concentration range 0.1-10 ng/mL for amiloride and 5.0-500.0 ng/mL for hydrochlorothiazide. The mean recovery was 41.1 and 81.5% for amiloride and hydrochlorothiazide respectively. The coefficient of variation of the assay was less than 11.2 and 5.2% for amiloride and hydrochlorothiazide, respectively, and the accuracy was 89.0-98.1 and 96.6-102.9% for amiloride and hydrochlorothiazide, respectively. The validated method can be applied to the pharmacokinetic study of amiloride and hydrochlorothiazide.

摘要

采用氨苯蝶啶和氢氯噻嗪(13)C,d2作为内标,验证了一种用于同时测定人血浆中阿米洛利和氢氯噻嗪的单一、简单且选择性的方法。化合物在反相柱上分离,等度流动相由2 mM pH 3.0的醋酸铵和乙腈(30:70,v/v)组成,并通过串联质谱在正/负离子模式下检测。使用简单的固相萃取从血浆中提取分析物和内标。在多反应监测模式下记录的离子跃迁为:正模式下,阿米洛利的m/z 230.1 → 116.0,内标氨苯蝶啶的m/z 254.1 → 237.1;负离子模式下,氢氯噻嗪的m/z 296.1 → 204.9,内标氢氯噻嗪(13)C,d2的m/z 299.2 → 205.8。血浆中阿米洛利的线性范围为0.1 - 10 ng/mL,氢氯噻嗪的线性范围为5.0 - 500.0 ng/mL。阿米洛利和氢氯噻嗪的平均回收率分别为41.1%和81.5%。该测定法的变异系数对于阿米洛利和氢氯噻嗪分别小于11.2%和5.2%,准确度对于阿米洛利和氢氯噻嗪分别为89.0 - 98.1%和96.6 - 102.9%。经验证的方法可应用于阿米洛利和氢氯噻嗪的药代动力学研究。

相似文献

1
A single, selective and simple validated method for simultaneous estimation of amiloride and hydrochlorothiazide in human plasma by liquid chromatography-tandem mass spectrometry.一种通过液相色谱-串联质谱法同时测定人血浆中阿米洛利和氢氯噻嗪的单一、选择性且简便的验证方法。
Biomed Chromatogr. 2012 Jan;26(1):95-100. doi: 10.1002/bmc.1632. Epub 2011 Apr 13.
2
Simultaneous determination of amiloride and hydrochlorothiazide in human plasma by liquid chromatography/tandem mass spectrometry with positive/negative ion-switching electrospray ionisation.采用正/负离子切换电喷雾电离液相色谱/串联质谱法同时测定人血浆中的阿米洛利和氢氯噻嗪。
Rapid Commun Mass Spectrom. 2007;21(21):3427-34. doi: 10.1002/rcm.3235.
3
A simple, selective and rapid validated method for estimation of anastrazole in human plasma by liquid chromatography-tandem mass spectrometry and its application to bioequivalence study.
Biomed Chromatogr. 2010 Jul;24(7):727-31. doi: 10.1002/bmc.1354.
4
A liquid chromatography/tandem mass spectrometry method for the simultaneous quantification of valsartan and hydrochlorothiazide in human plasma.一种用于同时定量测定人血浆中缬沙坦和氢氯噻嗪的液相色谱/串联质谱法。
J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Jun 1;852(1-2):436-42. doi: 10.1016/j.jchromb.2007.02.014. Epub 2007 Feb 15.
5
Simultaneous determination of bisoprolol and hydrochlorothiazide in human plasma by HPLC coupled with tandem mass spectrometry.高效液相色谱-串联质谱法同时测定人血浆中的比索洛尔和氢氯噻嗪。
J Chromatogr B Analyt Technol Biomed Life Sci. 2009 Jun 1;877(16-17):1689-97. doi: 10.1016/j.jchromb.2009.04.021. Epub 2009 Apr 18.
6
Simultaneous quantitative determination of olmesartan and hydrochlorothiazide in human plasma and urine by liquid chromatography coupled to tandem mass spectrometry.采用液相色谱-串联质谱法同时定量测定人血浆和尿液中的奥美沙坦和氢氯噻嗪。
J Chromatogr B Analyt Technol Biomed Life Sci. 2010 Mar 15;878(9-10):743-8. doi: 10.1016/j.jchromb.2010.01.009. Epub 2010 Jan 18.
7
Determination of metformin in human plasma using hydrophilic interaction liquid chromatography-tandem mass spectrometry.采用亲水作用液相色谱-串联质谱法测定人血浆中的二甲双胍。
J Chromatogr B Analyt Technol Biomed Life Sci. 2009 Nov 1;877(29):3695-700. doi: 10.1016/j.jchromb.2009.09.020. Epub 2009 Sep 17.
8
Quantification of galantamine in human plasma by validated liquid chromatography-tandem mass spectrometry using glimepride as an internal standard: application to bioavailability studies in 32 healthy Korean subjects.以格列美脲为内标,采用经过验证的液相色谱 - 串联质谱法对人血浆中加兰他敏进行定量分析:在32名健康韩国受试者中的生物利用度研究应用
J Chromatogr Sci. 2012 Oct;50(9):803-9. doi: 10.1093/chromsci/bms074. Epub 2012 Jun 28.
9
Validated LC-MS/MS assay for the quantitative determination of nalbuphine in human plasma and its application to a pharmacokinetic study.用于定量测定人血浆中纳布啡的经过验证的液相色谱-串联质谱法及其在药代动力学研究中的应用。
Biomed Chromatogr. 2011 Dec;25(12):1308-14. doi: 10.1002/bmc.1601. Epub 2011 Feb 18.
10
Liquid chromatography tandem mass spectrometry method for the quantification of amisulpride with LLOQ of 100 pg/mL using 100 microL of plasma.液相色谱串联质谱法测定氨磺必利,使用100微升血浆,定量下限为100皮克/毫升。
Biomed Chromatogr. 2008 Dec;22(12):1424-33. doi: 10.1002/bmc.1076.

引用本文的文献

1
Simultaneous quantification of amiloride and hydrochlorothiazide in human plasma by liquid chromatography-tandem mass spectrometry.采用液相色谱-串联质谱法同时测定人血浆中阿米洛利和氢氯噻嗪的含量。
J Pharm Anal. 2017 Oct;7(5):288-296. doi: 10.1016/j.jpha.2017.03.007. Epub 2017 Mar 24.